Abstract:OBJECTIVE To analyze the clinical and pathological features of children with Alport syndrome (AS). METHODS A series of 47 patients with AS from unrelated families hospitalized from Jan. 1990 to Jan. 2007 were involved in this study. The clinical and histopathological data were collected and analyzed. RESULTS Of the 47 cases, 32 were male and 15 female, M/F: 2.1:1. The patient's age ranged from 15 months to 13 years, mean 9 years. Thirty-nine of the 47 cases had positive family history, X-linked dominant inheritance AS was diagnosed in 37 cases, autosomal recessive inheritance AS in 2 cases. Gross hematuria or microscopic hematuria were found in 59.3% of the cases as the first manifestations, while 29.8% showed edema or proteinuria. The major clinical manifestations were isolated hematuria (23.4%), hematuria and proteinuria (36.2%), nephrotic syndrome (29.8%), and renal failure (10.6%). Hematuria and proteinuria existed in all the cases, while only 7 to 13 years children had nephrotic syndrome and renal failure. Of the 47 patients, 33 (70.2%) showed mesangial proliferative glomerulonephritis (MsPGN) under the light microscope, 13 (27.6%) focal segmental glomerulosclerosis (FSGS), 1 (2.1%) membrane proliferative glomerulonephritis (MPGN). For immunofluorescence, there was IgM (40.4%) as the dominant deposition in 19 patients, IgA in 9 (19.1%), IgG in 9 (19.1%), and 10 (21.4%) were negative. Thirty-nine cases showed typical glomerular basement membrane (GBM) pathological changes under electron microscope, while thin basement membrane in 8 cases; 46 showed abnormal skin and/or renal alpha-chain distribution. CONCLUSION For Alport syndrome, number of male patients was higher than that of female patients. There was a significant difference among different age groups. Hematuria might be present throughout the course, while urine protein increases gradually. MsPGN was the dominant pathological change. The GBM pathological changes in younger children is not typical, so the immunofluorescence test of alpha-chain in collagen IV should be used as an important diagnostic method.

Investigation of the Current Situation Regarding Diagnosis and Treatment of Alport Syndrome in Asian Countries: Results of Survey of the Asian Paediatric Nephrology Association (aspna) Tubular and Inherited Working Group

Pediatric Tubular and Inherited Disorders in Asia: Results of Preliminary Survey of the Asian Pediatric Nephrology Association (aspna) Tubular and Inherited Working Group

Investigation of current clinical practices and perceptions of patients and caregivers regarding Alport syndrome in South Korea

[Analysis of Diagnosis and Treatment of Alport Syndrome].

[Clinical and Pathological Study of 47 Cases with Alport Syndrome].

A review of clinical characteristics and genetic backgrounds in Alport syndrome

Alport Syndrome: Clinical Utility of Early Genetic Diagnosis in Children

Genetic diagnosis of Alport syndrome in 16 Chinese families

Attitudes Toward Genetic Diagnosis and Prenatal Diagnosis of X‐linked Alport Syndrome in China

[Expert consensus on the diagnosis and treatment of Alport syndrome (version 2023)]

Advances and Unmet Needs in Genetic, Basic and Clinical Science in Alport Syndrome: Report from the 2015 International Workshop on Alport Syndrome.

[Features of Clinical Phenotype and Genotype in Alport Syndrome: a Monocentric Study].

Prenatal Diagnosis And Genetic Counseling Of A Chinese Alport Syndrome Kindred

A comprehensive review of Alport syndrome: definition, pathophysiology, clinical manifestations, and diagnostic considerations

Alport syndrome: Expanding diagnosis and treatment

Phenotypic and genotypic features of Alport syndrome in Chinese children

Outcome of Renal Transplantation in Patients with Alport Syndrome: Report of 11 Cases

End-Stage Kidney Disease Due to Alport Syndrome: Outcomes in 296 Consecutive Australia and New Zealand Dialysis and Transplant Registry Cases

Autosomal Dominant Alport Syndrome Caused by a Novel COL4A4 Gene Mutation:a Case Report and Literature Review

Identification of a Novel COL4A5 Mutation in the Proband Initially Diagnosed As IgAN from a Chinese Family with X-linked Alport Syndrome.

Spectrum of Alport syndrome in an Indian cohort